1-6 of 6
Bunzo Matsuura
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Simple Scoring System for Esophagogastric Varices Prediction in Hepatocellular Carcinoma Patients without Liver Stiffness Evaluation

Available to Purchase
Subject Area:
Oncology
Atsushi Hiraoka, Fujimasa Tada, Hideko Ohama, Mai Fukumoto, Kana Matsuoka, Takuya Matsuda, Kosuke Nakatani, Emi Yanagihara, Hironobu Saneto, Hirofumi Izumoto, Taisei Murakami, Kei Onishi, Shogo Kitahata, Kozue Kanemitsu-Okada, Tomoe Kawamura, Taira Kuroda, Hideki Miyata, Eiji Tsubouchi, Masashi Hirooka, Masanori Abe, Bunzo Matsuura, Tomoyuki Ninomiya, Yoichi Hiasa
Journal: Oncology
Oncology (2024) 102 (4): 291–298.
https://doi.org/10.1159/000533672
Published Online: 11 October 2023
View articletitled, Simple Scoring System for Esophagogastric Varices Prediction in Hepatocellular Carcinoma Patients without Liver Stiffness Evaluation
Open the PDF for Simple Scoring System for Esophagogastric Varices Prediction in Hepatocellular Carcinoma Patients without Liver Stiffness Evaluation in another window
Journal Articles

Usefulness of aMAP Risk Score for Predicting Recurrence after Curative Treatment for Hepatocellular Carcinoma within Milan Criteria

Open Access
Subject Area:
Karger e-Journal Backfile Collection 2023 , Oncology
Hideko Ohama, Atsushi Hiraoka, Fujimasa Tada, Kanako Kato, Yoshiko Fukunishi, Emi Yanagihara, Masaya Kato, Hironobu Saneto, Hirofumi Izumoto, Hidetaro Ueki, Takeaki Yoshino, Shogo Kitahata, Tomoe Kawamura, Taira Kuroda, Yoshifumi Suga, Hideki Miyata, Masashi Hirooka, Masanori Abe, Bunzo Matsuura, Tomoyuki Ninomiya, Yoichi Hiasa
Journal: Oncology
Oncology (2023) 101 (9): 575–583.
https://doi.org/10.1159/000530987
Published Online: 17 July 2023
View articletitled, Usefulness of aMAP Risk Score for Predicting Recurrence after Curative Treatment for Hepatocellular Carcinoma within Milan Criteria
Open the PDF for Usefulness of aMAP Risk Score for Predicting Recurrence after Curative Treatment for Hepatocellular Carcinoma within Milan Criteria in another window
Journal Articles

Combination of Resection and Ablative Treatment for Hepatocellular Carcinoma: Usefulness of Complementary Radiofrequency Ablation

Available to Purchase
Subject Area:
Oncology
Atsushi Hiraoka, Masashi Hirooka, Hironori Ochi, Yohei Koizumi, Hirofumi Izumoto, Hidetaro Ueki, Miho Tsuruta, Atsushi Ono, Takeaki Yoshino, Toshihiko Aibiki, Tomonari Okudaira, Hiroka Yamago, Yoshifumi Suga, Ryuichiro Iwasaki, Kenichiro Mori, Hideki Miyata, Masato Kishida, Eiji Tsubouchi, Masanori Abe, Bunzo Matsuura, Tomoyuki Ninomiya, Kouji Joko, Hideki Kawasaki, Yoichi Hiasa, Kojiro Michitaka
Journal: Oncology
Oncology (2019) 96 (5): 242–251.
https://doi.org/10.1159/000496225
Published Online: 20 March 2019
View articletitled, Combination of Resection and Ablative Treatment for Hepatocellular Carcinoma: Usefulness of Complementary Radiofrequency Ablation
Open the PDF for Combination of Resection and Ablative Treatment for Hepatocellular Carcinoma: Usefulness of Complementary Radiofrequency Ablation in another window
Journal Articles

Validation of Newly Proposed Time to Transarterial Chemoembolization Progression in Intermediate-Stage Hepatocellular Carcinoma Cases

Available to Purchase
Subject Area:
Oncology
Hirofumi Izumoto, Atsushi Hiraoka, Yoshihiro Ishimaru, Tadashi Murakami, Shogo Kitahata, Hidetaro Ueki, Toshihiko Aibiki, Tomonari Okudaira, Yuji Miyamoto, Hiroka Yamago, Ryuichiro Iwasaki, Hideomi Tomida, Kenichiro Mori, Masato Kishida, Eiji Tsubouchi, Hideki Miyata, Tomoyuki Ninomiya, Hideki Kawasaki, Masashi Hirooka, Bunzo Matsuura, Masanori Abe, Yoichi Hiasa, Kojiro Michitaka, Masatoshi Kudo
Journal: Oncology
Oncology (2017) 93 (Suppl. 1): 120–126.
https://doi.org/10.1159/000481242
Published Online: 20 December 2017
View articletitled, Validation of Newly Proposed Time to Transarterial Chemoembolization Progression in Intermediate-Stage Hepatocellular Carcinoma Cases
Open the PDF for Validation of Newly Proposed Time to Transarterial Chemoembolization Progression in Intermediate-Stage Hepatocellular Carcinoma Cases in another window
Journal Articles

Tumor Markers AFP, AFP-L3, and DCP in Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization

Available to Purchase
Subject Area:
Oncology
Atsushi Hiraoka, Yoshihiro Ishimaru, Hideki Kawasaki, Toshihiko Aibiki, Tomonari Okudaira, Akiko Toshimori, Tomoe Kawamura, Hiroka Yamago, Hiromasa Nakahara, Yoshifumi Suga, Nobuaki Azemoto, Hideki Miyata, Yasunao Miyamoto, Tomoyuki Ninomiya, Masashi Hirooka, Masanori Abe, Bunzo Matsuura, Yoichi Hiasa, Kojiro Michitaka
Journal: Oncology
Oncology (2015) 89 (3): 167–174.
https://doi.org/10.1159/000381808
Published Online: 12 May 2015
View articletitled, Tumor Markers AFP, AFP-L3, and DCP in Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization
Open the PDF for Tumor Markers AFP, AFP-L3, and DCP in Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization in another window
Journal Articles

High Orotate Phosphoribosyltransferase Gene Expression Predicts Complete Response to Chemoradiotherapy in Patients with Squamous Cell Carcinoma of the Esophagus

Available to Purchase
Subject Area:
Oncology
Takeshi Kajiwara, Tomohiro Nishina, Ichinosuke Hyodo, Toshikazu Moriwaki, Shinji Endo, Junichirou Nasu, Shinichiro Hori, Bunzo Matsuura, Yoichi Hiasa, Morikazu Onji
Journal: Oncology
Oncology (2009) 76 (5): 342–349.
https://doi.org/10.1159/000209964
Published Online: 23 March 2009
View articletitled, High Orotate Phosphoribosyltransferase Gene Expression Predicts Complete Response to Chemoradiotherapy in Patients with Squamous Cell Carcinoma of the Esophagus
Open the PDF for High Orotate Phosphoribosyltransferase Gene Expression Predicts Complete Response to Chemoradiotherapy in Patients with Squamous Cell Carcinoma of the Esophagus in another window